Cargando…

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance

Background: The advancement of COVID-19 vaccination programs globally has been viewed as an integral strategy to reduce both the number of COVID-19 cases and consequential complications of COVID-19, particularly for high-risk patient groups. There are limited data on the antibody response and protec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chinnadurai, Rajkumar, Wu, Henry H. L., Cox, Eleanor, Moore, Jayne, Clough, Toni, Lamerton, Elizabeth, Donne, Rosie, O’Riordan, Edmond, Poulikakos, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028840/ https://www.ncbi.nlm.nih.gov/pubmed/35455248 http://dx.doi.org/10.3390/vaccines10040498

Ejemplares similares

Increasing Uptake of COVID-19 Vaccination and Reducing Health Inequalities in Patients on Renal Replacement Therapy—Experience from a Single Tertiary Centre
por: Poulikakos, Dimitrios, et al.
Publicado: (2022)

Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
por: Goga, Ameena, et al.
Publicado: (2022)

A Quality Improvement Project to Minimize COVID-19 Infections in Patients Receiving Haemodialysis and the Role of Routine Surveillance Using Nose and Throat Swabs for SARS-CoV-2 rRT-PCR and Serum Antibody Testing
por: Poulikakos, Dimitrios, et al.
Publicado: (2022)

Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis
por: Toda, Masataro, et al.
Publicado: (2023)

Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)
por: Barbui, Tiziano, et al.
Publicado: (2022)

Occupational exposure of healthcare workers to COVID-19 and infection prevention control measures in haemodialysis facilities in North West of England
por: Gray, Simon, et al.
Publicado: (2021)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

Correlation of Breakthrough Infection During the Omicron Wave With Seropositivity of Vaccinated Patients Undergoing Hemodialysis
por: Patnaik, Aswini P, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
por: Keyel, Alexander C., et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
por: Regenhardt, Elisa, et al.
Publicado: (2023)

SARS-CoV-2 seroepidemiology in paediatric population during Delta and Omicron predominance
por: Filippatos, Filippos, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Replacement of Delta as Predominant Variant, Puerto Rico
por: Santiago, Gilberto A., et al.
Publicado: (2023)

A low rate of end-stage kidney disease in membranous nephropathy: A single centre study over 2 decades
por: Storrar, Joshua, et al.
Publicado: (2022)

Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
por: Servellita, Venice, et al.
Publicado: (2022)

Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan
por: Jamal, Zunera, et al.
Publicado: (2022)

Antibody titres in fully vaccinated healthcare workers with and without breakthrough infection during the Delta and Omicron waves
por: Chandrasingh, Sindhulina, et al.
Publicado: (2023)

Long-term humoral response following Delta and Omicron BA.1 co-infection
por: Saade, Carla, et al.
Publicado: (2023)

Impact of Shielding and First Dose of COVID-19 Vaccination in Kidney Transplant Recipients
por: Middleton, Rachel J., et al.
Publicado: (2021)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

Vaccine breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota, and Omicron
por: Martínez-González, Brenda, et al.
Publicado: (2022)

COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods
por: Mayr, Florian B., et al.
Publicado: (2022)

Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
por: Anft, Moritz, et al.
Publicado: (2022)

Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
por: Stærke, Nina Breinholt, et al.
Publicado: (2022)

Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5
por: Bormann, Maren, et al.
Publicado: (2023)

Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Comparison of clinical characteristics of COVID-19 in pregnant women between the Delta and Omicron variants of concern predominant periods
por: Shoji, Kensuke, et al.
Publicado: (2023)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
por: Søraas, Arne, et al.
Publicado: (2022)

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022)

Omicron breakthrough infections in vaccinated or previously infected hamsters
por: Zhou, Jie, et al.
Publicado: (2023)

Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals
por: Lechmere, Thomas, et al.
Publicado: (2022)

Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2
por: Yang, Yang, et al.
Publicado: (2022)

RNA loads of severe acute respiratory syndrome coronavirus 2 in patients with breakthrough coronavirus disease 2019 caused by the Delta and Omicron variants
por: de Michelena, Paula, et al.
Publicado: (2023)

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Erratum: Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
Publicado: (2023)

Safely reducing haemodialysis frequency during the COVID-19 pandemic
por: Lodge, Michelle Da Silva, et al.
Publicado: (2020)

Spike Mutation Profiles Associated With SARS-CoV-2 Breakthrough Infections in Delta Emerging and Predominant Time Periods in British Columbia, Canada
por: Fibke, Chad D., et al.
Publicado: (2022)

Multimorbidity and Frailty Are the Key Characteristics of Patients Hospitalized with COVID-19 Breakthrough Infection during Delta Variant Predominance in Italy: A Retrospective Study
por: Ticinesi, Andrea, et al.
Publicado: (2022)

The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
por: Sendi, Parham, et al.
Publicado: (2022)

SARS-CoV-2 Vaccination and Clinical Presentation of COVID-19 in Patients Hospitalized during the Delta- and Omicron-Predominant Periods
por: Stupica, Daša, et al.
Publicado: (2023)

HETEROLOGOUS THIRD AND FOURTH DOSE VACCINE TO REDUCE SEVERITY AND MORTALITY IN COVID-19 PATIENTS DURING DELTA AND OMICRON PREDOMINANT IN THAILAND
por: Chariyalertsak, S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h95pcnufc07tha47v0ous0bina